Mumbai, Oct. 2 -- The Maharashtra Food and Drug Administration (FDA) has cancelled the wholesale drug sale licences of M/s Cipla Pharma & Life Sciences Ltd at Godown No. A, Wadaki, Pune, following directions of the Bombay High Court.
FDA Commissioner Tukaram Mundhe said the action was taken after completion of the prescribed procedure in Writ Petition No. 11376/2026.
Following the High Court's directions, the earlier action was withdrawn and a revised show-cause notice was issued on September 4. The company submitted its written reply on September 11 and was given a personal hearing on September 21.
After considering the company's reply, submissions made during the hearing, inspection findings and applicable legal provisions, the Assista...